Study of Alfimeprase's Ability to Dissolve Blood Clots in the Leg and Help Prevent the Need for Surgery
Status:
Terminated
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to directly compare the safety and efficacy of intra-thrombus
alfimeprase 0.3 mg/kg with placebo in acute peripheral arterial occlusion (PAO) as measured
by a 30 day open vascular free surgery rate.